The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Adverse Health Outcomes in Women Exposed In Utero to Diethylstilbestrol
Open accessAbstract
BACKGROUND: Before 1971, several million women were exposed in utero to diethylstilbestrol (DES) given to their mothers to prevent pregnancy complications. Several adverse outcomes have been linked to such exposure, but their cumulative effects are not well understood. METHODS: We combined data from three studies initiated in the 1970s with continued long-term follow-up of 4653 women exposed in utero to DES and 1927 unexposed controls. We assessed the risks of 12 adverse outcomes linked to DES exposure, including cumulative risks to 45 years of age for reproductive outcomes and to 55 years of age for other outcomes, and their relationships to the baseline presence or absence of vaginal epithelial changes, which are correlated with a higher dose of, and earlier exposure to, DES in utero. RESULTS: Cumulative risks in women exposed to DES, as compared with those not exposed, were as follows: for infertility, 33.3% vs. 15.5% (hazard ratio, 2.37; 95% confidence interval [CI], 2.05 to 2.75); spontaneous abortion, 50.3% vs. 38.6% (hazard ratio, 1.64; 95% CI, 1.42 to 1.88); preterm delivery, 53.3% vs. 17.8% (hazard ratio, 4.68; 95% CI, 3.74 to 5.86); loss of second-trimester pregnancy, 16.4% vs. 1.7% (hazard ratio, 3.77; 95% CI, 2.56 to 5.54); ectopic pregnancy, 14.6% vs. 2.9% (hazard ratio, 3.72; 95% CI, 2.58 to 5.38); preeclampsia, 26.4% vs. 13.7% (hazard ratio 1.42; 95% CI, 1.07 to 1.89); stillbirth, 8.9% vs. 2.6% (hazard ratio, 2.45; 95% CI, 1.33 to 4.54); early menopause, 5.1% vs. 1.7% (hazard ratio, 2.35; 95% CI, 1.67 to 3.31); grade 2 or higher cervical intraepithelial neoplasia, 6.9% vs. 3.4% (hazard ratio, 2.28; 95% CI, 1.59 to 3.27); and breast cancer at 40 years of age or older, 3.9% vs. 2.2% (hazard ratio, 1.82; 95% CI, 1.04 to 3.18). For most outcomes, the risks among exposed women were higher for those with vaginal epithelial changes than for those without such changes. CONCLUSIONS: In utero exposure of women to DES is associated with a high lifetime risk of a broad spectrum of adverse health outcomes. (Funded by the National Cancer Institute.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Cox, D. R., & Oakes, D. (2018) · Chapman & Hall/CRC eBooks · doi:10.1201/9781315137438 · Cited by 6,234
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
Diamanti-Kandarakis, E., Bourguignon, J.-P., Giudice, L. C., Hauser, R., Prins, G. S., Soto, A. M., Zoeller, R. T., & Gore, A. C. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0002 · Cited by 4,585
Herbst, A. L., Ulfelder, H., & Poskanzer, D. C. (1971) · New England Journal of Medicine · doi:10.1056/nejm197104222841604 · Cited by 2,520
Self-citationAGREEMENT BETWEEN QUESTIONNAIRE DATA AND MEDICAL RECORDS
HARLOW, S. D., & LINET, M. S. (1989) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115129 · Cited by 609
OEstrogenic Activity of Certain Synthetic Compounds
DODDS, E. C., GOLDBERG, L., LAWSON, W., & ROBINSON, R. (1938) · Nature · doi:10.1038/141247b0 · Cited by 514
Herbst, A. L., & Scully, R. E. (1970) · Cancer · doi:10.1002/1097-0142(197004)25:4<745::aid-cncr2820250402>3.0.co;2-2 · Cited by 456
Self-citationPrenatal Diethylstilbestrol Exposure and Risk of Breast Cancer
Palmer, J. R., Wise, L. A., Hatch, E. E., Troisi, R., Titus-Ernstoff, L., Strohsnitter, W., Kaufman, R., Herbst, A. L., Noller, K. L., Hyer, M., et al. (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0109 · Cited by 347
Self-citationFOLLOW-UP STUDY OF MALE AND FEMALE OFFSPRING OF DES-EXPOSED MOTHERS
BIBBO, M., GILL, W. B., AZIZI, F., BLOUGH, R., FANG, V. S., ROSENFIELD, R. L., SCHUMACHER, G. F. B., SLEEPER, K., SONEK, M. G., & WEID, G. L. (1977) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-197706000-00013 · Cited by 311
Does the Administration of Diethylstilbestrol during Pregnancy have Therapeutic Value?
Dieckmann, W. J., Davis, M. E., Rynkiewicz, L. M., & Pottinger, R. E. (1953) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(16)38617-3 · Cited by 302
Does the administration of diethylstilbestrol during pregnancy have therapeutic value?
Dieckmann, W. J., Davis, M. E., Rynkiewicz, L. M., & Pottinger, R. E. (1999) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(99)70410-2 · Cited by 265
Herbst, A. L., Poskanzer, D. C., Robboy, S. J., Friedlander, L., & Scully, R. E. (1975) · New England Journal of Medicine · doi:10.1056/nejm197502132920704 · Cited by 261
Self-citationOlson, J. E., Shu, X. O., Ross, J. A., Pendergrass, T., & Robison, L. L. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009032 · Cited by 255
Diethylstilbestrol in the prevention and treatment of complications of pregnancy
Watkins, O. (1948) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(48)90440-2 · Cited by 221
A COMPARISON OF PREGNANCY HISTORY RECALL AND MEDICAL RECORDS
TILLEY, B. C., BARNES, A. B., BERGSTRALH, E., LABARTHE, D., NOLLER, K. L., COLTON, T., & ADAM, E. (1985) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113997 · Cited by 187
Self-citationIn utero exposures and the incidence of endometriosis
Missmer, S. A., Hankinson, S. E., Spiegelman, D., Barbieri, R. L., Michels, K. B., & Hunter, D. J. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.04.065 · Cited by 184
Cancer risk in women prenatally exposed to diethylstilbestrol
Troisi, R., Hatch, E. E., Titus‐Ernstoff, L., Hyer, M., Palmer, J. R., Robboy, S. J., Strohsnitter, W. C., Kaufman, R., Herbst, A. L., & Hoover, R. N. (2007) · International Journal of Cancer · doi:10.1002/ijc.22631 · Cited by 179
Self-citationBreast Cancer in Mothers Given Diethylstilbestrol in Pregnancy
Greenberg, E. R., Ab, B., Resseguie, L. J., Barrett, J. A., Burnside, S., Lanza, L. L., Rk, N., Stevens, M., Young, R. H., & Colton, T. (1984) · New England Journal of Medicine · doi:10.1056/nejm198411293112201 · Cited by 160
Self-citationContinued Follow-up of Pregnancy Outcomes in Diethylstilbestrol-exposed Offspring
Kaufman, R. H., Adam, E., Hatch, E. E., Noller, K. L., Herbst, A. L., Palmer, J. R., & HOOVER, R. N. (2000) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(00)00959-5 · Cited by 154
Self-citationBreast Cancer in Mothers Given Diethylstilbestrol in Pregnancy
(1985) · New England Journal of Medicine · doi:10.1056/nejm198504183121612 · Cited by 143
Prenatal diethylstilbestrol (DES) exposure is associated with uterine leiomyoma development
Baird, D. D., & Newbold, R. R. (2005) · Reproductive Toxicology · doi:10.1016/j.reprotox.2005.01.002 · Cited by 120
Infertility among Women Exposed Prenatally to Diethylstilbestrol
Palmer, J. R. (2001) · American Journal of Epidemiology · doi:10.1093/aje/154.4.316 · Cited by 109
Self-citationVerloop, J., van Leeuwen, F. E., Helmerhorst, T. J. M., van Boven, H. H., & Rookus, M. A. (2010) · Cancer Causes & Control · doi:10.1007/s10552-010-9526-5 · Cited by 106
D’Aloisio, A. A., Baird, D. D., DeRoo, L. A., & Sandler, D. P. (2009) · Environmental Health Perspectives · doi:10.1289/ehp.0901423 · Cited by 105
Hatch, E. E., Herbst, A. L., Hoover, R. N., Noller, K. L., Adám, E., Kaufman, R. H., Palmer, J. R., Titus-Ernstoff, L. T., Hyer, M., Hartge, P. A., et al. (2001) · Cancer Causes & Control · doi:10.1023/a:1012229112696 · Cited by 84
Self-citationAge at Natural Menopause in Women Exposed to Diethylstilbestrol in Utero
Hatch, E. E., Troisi, R. J., Wise, L. A., Hyer, M., Palmer, J. R., Titus-Ernstoff, L. T., Strohsnitter, W. C., Kaufman, R. H., Adam, E., Noller, K. L., et al. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj257 · Cited by 79
Self-citationDiethylstilbestrol in the prevention and treatment of complications of pregnancy
Smith, O. W. (1999) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(99)70409-6 · Cited by 69
Effect of stilbestrol on pregnancy compared to the effect of a placebo
Ferguson, J. H. (1953) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(83)90615-4 · Cited by 67
Psychosexual Characteristics of Men and Women Exposed Prenatally to Diethylstilbestrol
Titus-Ernstoff, L. T., Perez, K. M., Hatch, E. E., Troisi, R. J., Palmer, J. R., Hartge, P. A., Hyer, M., Kaufman, R. H., Adam, E., Strohsnitter, W. C., et al. (2003) · Epidemiology · doi:10.1097/01.ede.0000039059.38824.b2 · Cited by 60
Self-citationDiethylstilbestrol Exposure in Utero and Depression in Women
O’Reilly, É. J., Mirzaei, F., Forman, M. R., & Ascherio, A. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq023 · Cited by 48
Risk of Benign Gynecologic Tumors in Relation to Prenatal Diethylstilbestrol Exposure
Wise, L. A., Palmer, J. R., Rowlings, K., Kaufman, R. H., Herbst, A. L., Noller, K. L., Titus-Ernstoff, L. T., Troisi, R. J., Hatch, E. E., & Robboy, S. J. (2005) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000147839.74848.7c · Cited by 43
Self-citationEnvironmental hormones: Multiple pathways for response may lead to multiple disease outcomes
Tilghman, S. L., Nierth-Simpson, E. N., Wallace, R. B., Burow, M. E., & McLachlan, J. A. (2010) · Steroids · doi:10.1016/j.steroids.2010.05.004 · Cited by 40
Cited by
EDC-2: the endocrine society's second scientific statement on endocrine-disrupting chemicals
Gore, A. C., Chappell, V. A., Fenton, S. E., Flaws, J. A., Nadal, A., Prins, G. S., Toppari, J., & Zoeller, R. T. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1010 · Cited by 2,407
Łukasiewicz, S., Czeczelewski, M., Forma, A., Baj, J., Sitarz, R., & Stanisławek, A. (2021) · Cancers · doi:10.3390/cancers13174287 · Cited by 1,960
State-of-the-science of endocrine disrupting chemicals, 2012
Bergman, Å., Heindel, J., Jobling, S., Kidd, K., & Zoeller, R. T. (2012) · Toxicology Letters · doi:10.1016/j.toxlet.2012.03.020 · Cited by 1,388
Early-life exposure to EDCs: role in childhood obesity and neurodevelopment
Braun, J. M. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.186 · Cited by 930
Mammary stem cells and the differentiation hierarchy: current status and perspectives
Visvader, J. E., & Stingl, J. (2014) · Genes & Development · doi:10.1101/gad.242511.114 · Cited by 562
Metadata
- Authors
- Hoover, R. N., Hyer, M., Pfeiffer, R. M., Adam, E., Bond, B., Cheville, A. L., Colton, T., Hartge, P., Hatch, E. E., Herbst, A. L., Karlan, B. Y., Kaufman, R., Noller, K. L., Palmer, J. R., Robboy, S. J., Saal, R. C., Strohsnitter, W., Titus-Ernstoff, L., & Troisi, R.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2011-10-06
- Volume
- 365
- Issue
- 14
- Pages
- 1304-1314
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2145926321
- Cited by
- 444
- References
- 32
- FWCI
- 20.58
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.